Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Carballo

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
European Heart Journal. Acute Cardiovascular Care|June 5, 2018
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort studyBaris Gencer, Fabio Rigamonti, David Nanchen, et al.
Atherosclerosis|January 14, 2015
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromesBaris Gencer, Reto Auer, David Nanchen, et al.
European Journal of Clinical Investigation|July 27, 2025
Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromesMaëlle Achard, Cédric Follonier, Evelyne Fournier, et al.
Journal of the American Heart Association|November 11, 2017
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary SyndromesBaris Gencer, Konstantinos C Koskinas, Lorenz Räber, et al.
AIDS Research and Therapy|February 24, 2015
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort studyDavid Carballo, Cécile Delhumeau, Sebastian Carballo, et al.
Environment International|July 24, 2012
Long-term exposure to traffic-related PM(10) and decreased heart rate variability: is the association restricted to subjects taking ACE inhibitors?Martin Adam, Denise Felber Dietrich, Emmanuel Schaffner, et al.
Circulation|October 11, 2012
Premature atrial contractions in the general population: frequency and risk factorsDavid Conen, Martin Adam, Frederic Roche, et al.
Atherosclerosis Plus|October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesCédric Follonier, Gabriel Rabassa, Mattia Branca, et al.
Plos One|March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medicationsReto Auer, Baris Gencer, Lorenz Räber, et al.
European Journal of Preventive Cardiology|April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromesBaris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
European Heart Journal. Acute Cardiovascular Care|June 5, 2018
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort studyBaris Gencer, Fabio Rigamonti, David Nanchen, et al.
Atherosclerosis|January 14, 2015
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromesBaris Gencer, Reto Auer, David Nanchen, et al.
European Journal of Clinical Investigation|July 27, 2025
Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromesMaëlle Achard, Cédric Follonier, Evelyne Fournier, et al.
Journal of the American Heart Association|November 11, 2017
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary SyndromesBaris Gencer, Konstantinos C Koskinas, Lorenz Räber, et al.
AIDS Research and Therapy|February 24, 2015
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort studyDavid Carballo, Cécile Delhumeau, Sebastian Carballo, et al.
Environment International|July 24, 2012
Long-term exposure to traffic-related PM(10) and decreased heart rate variability: is the association restricted to subjects taking ACE inhibitors?Martin Adam, Denise Felber Dietrich, Emmanuel Schaffner, et al.
Circulation|October 11, 2012
Premature atrial contractions in the general population: frequency and risk factorsDavid Conen, Martin Adam, Frederic Roche, et al.
Atherosclerosis Plus|October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesCédric Follonier, Gabriel Rabassa, Mattia Branca, et al.
Plos One|March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medicationsReto Auer, Baris Gencer, Lorenz Räber, et al.
European Journal of Preventive Cardiology|April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromesBaris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Pageof 10